業績

Meroni PL, Borghi MO, Amengual O, Atsumi T, Bertolaccini L, Cohen H, Grossi C, Roubey R, Sciascia S, Tebo A, Willis R, Erkan D, Devreese KMJ. 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria Solid Phase-based Antiphospholipid Antibody (aPL) Domain - Collaborative Efforts of APS ACTION and ISTH-SSC to Harmonize ELISA and non-ELISA aPL Tests: Communication from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.

J Thromb Haemost. 2024 Oct 10:S1538-7836(24)00569-5. doi:

10.1016/j.jtha.2024.09.021. Epub ahead of print.

Kudo Y, Hara K, Murayama M, Kaga S, Omotehara S, Iwai T, Kato M, Tomaru U, Matsuno Y, Ishizu A.

A novel ultrasound finding for the diagnosis of giant cell arteritis:

Comparison with temporal artery biopsy findings.

Journal of Clinical Ultrasound. in press.

IF 1.2

Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H, Japan VEXAS study group Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.

Rheumatology

Masataka Umeda, Kohei Karino, Abhigyan Satyam, Nobuya Yoshida, Ryo Hisada, Rhea Bhargava, Theodoros Vichos, Ana Laura Kunzler, Takashi Igawa, Kunihiro Ichinose, Kenta Torigoe, Tomoya Nishino, Takahiro Maeda, Caroline A Owen, Reza Abdi, Atsushi Kawakami, George C Tsokos Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells which Enhances TGF-β1 Activation and Promotes Tissue Fibrosis in Lupus Nephritis Arthritis & Rheumatology. in press

IF：10.995

Ikumi Shigesawa, Akinobu Nakamura, Yuki Yamauchi, Shinichiro Kawata, Asuka Miyazaki, Hiroshi Nomoto, Hiraku Kameda, Yasuo Terauchi, Tatsuya Atsumi Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice J Diabetes Investig, in press.

IF: 3.1

Wei J, Fujieda Y, Fujita Y, Ogata Y, Hisada R, Kono M, Amengual O, Kato M and Atumi T.

Phosphatidylserine-Dependent Anti-prothrombin Antibodies as a Key Predictor for Systemic Lupus Erythematosus in Patients with Primary Antiphospholipid Syndrome: A retrospective longitudinal cohort study Modern Rheumatology.

IF: 2.2

Izuka S, Umezawa N, Komai T, Sugimori Y, Kimura N, Mizoguchi F, Fujieda Y, Ninagawa K, Iwasaki T, Suzuki K, Takeuchi T, Ohmura K, Mimori T, Atsumi T, Kawakami E, Suzuki A, Kochi Y, Yamamoto K, Yasuda S, Okamura T, Ota M, Fujio K The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions.

Arthritis & Rheumatology

IF：10.995

Kidoguchi G, Yoshida Y, Watanabe H, Sugimoto T, Mokuda S, Kida T, Yajima N, Omura S, Nakagomi D, Abe Y, Kadoya M, Takizawa N, Nomura A, Kukida Y, Kondo N, Yamano Y, Yanagida T, Endo K, Matsui K, Takeuchi T, Ichinose K, Kato M, Yanai R, Matsuo Y, Shimojima Y, Nishioka R, Okazaki R, Takata T, Ito T, Moriyama M, Takatani A, Miyawaki Y, Ito-Ihara T, Kawaguchi T, Kawahito Y, Hirata S.

Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVAS. Clinical Rheumatology. in press.

IF：2.9

Takeyama S, Kono M, Aso K, Kamada K, Tada M, Tarumi M, Kosumi Y, Yoshimura M, Ninagawa K, Hisada R, Fujieda Y, Kato M, Amengual O, Atsumi T.

Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus.

Modern Rheumatology. in press.

IF: 2.2

The Best Doctors in Japan 2024-2025 　加藤　将先生